Review



normal pulmonary artery smooth muscle cells (pasmcs) from conduit pulmonary arteries  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza normal pulmonary artery smooth muscle cells (pasmcs) from conduit pulmonary arteries
    Normal Pulmonary Artery Smooth Muscle Cells (Pasmcs) From Conduit Pulmonary Arteries, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/pulmonary+artery+smooth+muscle+cells/pmc05451598-241-52-55
    Average 90 stars, based on 1 article reviews
    normal pulmonary artery smooth muscle cells (pasmcs) from conduit pulmonary arteries - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells
    Article Snippet: addition, PDGF-induced increase in collagen-I protein levels was attenuated by BMP4 ( , B and C ). .. These data indicate that BMP4 inhibits PDGF-induced cell proliferation and collagen synthesis in PASMCs. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Fig. 1. caption a7 Bone morphogenetic protein 4 (BMP4) inhibits PDGF-stimulated cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). .. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/m



    Similar Products

    90
    JIAHE INTERNATIONAL CO LTD valved pulmonary arterial conduit
    Valved Pulmonary Arterial Conduit, supplied by JIAHE INTERNATIONAL CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/valved+pulmonary+arterial+conduit/pmc07401300-41-4-13
    Average 90 stars, based on 1 article reviews
    valved pulmonary arterial conduit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza normal pulmonary artery smooth muscle cells (pasmcs) from conduit pulmonary arteries
    Normal Pulmonary Artery Smooth Muscle Cells (Pasmcs) From Conduit Pulmonary Arteries, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/pulmonary+artery+smooth+muscle+cells/pmc05451598-241-52-55
    Average 90 stars, based on 1 article reviews
    normal pulmonary artery smooth muscle cells (pasmcs) from conduit pulmonary arteries - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Lonza conduit pulmonary arteries
    Conduit Pulmonary Arteries, supplied by Lonza, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/D-PASMC+-+Diseased+Human+Pulmonary+Artery+Smooth+Muscle+Cells/pmc05451598-370-52-55
    Average 93 stars, based on 1 article reviews
    conduit pulmonary arteries - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Lonza normal human pasmcs from conduit pulmonary arteries
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    Normal Human Pasmcs From Conduit Pulmonary Arteries, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/normal+human+pasmcs+from+conduit+pulmonary+arteries/pmc05451598-236-7-17
    Average 90 stars, based on 1 article reviews
    normal human pasmcs from conduit pulmonary arteries - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Shelhigh Inc stentless porcine pulmonary valve with arterial root conduits
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    Stentless Porcine Pulmonary Valve With Arterial Root Conduits, supplied by Shelhigh Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/stentless+porcine+pulmonary+valve+with+arterial+root+conduits/pm28033080-110-26-28
    Average 90 stars, based on 1 article reviews
    stentless porcine pulmonary valve with arterial root conduits - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Vascutek Inc rv-to-pulmonary artery conduit trifecta
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    Rv To Pulmonary Artery Conduit Trifecta, supplied by Vascutek Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/rv+to+pulmonary+artery+conduit+trifecta/pm27000578-69-35-37
    Average 90 stars, based on 1 article reviews
    rv-to-pulmonary artery conduit trifecta - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Labcor Inc right ventricular–pulmonary artery conduit anastomosis
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    Right Ventricular–Pulmonary Artery Conduit Anastomosis, supplied by Labcor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/pulmonary+conduit/10__1017_slash_s1047951113002151-57-21-25
    Average 90 stars, based on 1 article reviews
    right ventricular–pulmonary artery conduit anastomosis - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Shelhigh Inc pulmonary artery conduit
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    Pulmonary Artery Conduit, supplied by Shelhigh Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/pulmonary+valve+conduit/pm22424506-29-6-5
    Average 90 stars, based on 1 article reviews
    pulmonary artery conduit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Shelhigh Inc no-react treated pulmonary artery conduit
    Bone morphogenetic protein <t>4</t> <t>(BMP4)</t> inhibits <t>PDGF-stimulated</t> cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.
    No React Treated Pulmonary Artery Conduit, supplied by Shelhigh Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/conduit+pulmonary+arteries/pulmonary+valve+conduit/pm22424506-25-26-25
    Average 90 stars, based on 1 article reviews
    no-react treated pulmonary artery conduit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Bone morphogenetic protein 4 (BMP4) inhibits PDGF-stimulated cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: Bone morphogenetic protein 4 (BMP4) inhibits PDGF-stimulated cell proliferation and collagen synthesis in normal pulmonary artery smooth muscle cells (PASMCs) from conduit pulmonary arteries (Lonza). PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting bromodeoxyuridine (BrdU) incorporation and intracellular collagen-I protein levels (B and C) were measured by Western blot analysis. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Incubation, BrdU Incorporation Assay, Western Blot, Control

    BMP4 inhibits PDGF-induced TGF-β1 signaling pathway in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h, and then p-Smad1/5, total Smad1/5, p-Smad2/3, and total Smad2/3 were measured Western blot. A: representative immunoblots of p-Smad1/5, total Smad1/5, p-Smad2/3, and total Smad2/3. B and C: bar graphs showing the changes in protein levels of p-Smad1/5 and p-Smad2/3. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 inhibits PDGF-induced TGF-β1 signaling pathway in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h, and then p-Smad1/5, total Smad1/5, p-Smad2/3, and total Smad2/3 were measured Western blot. A: representative immunoblots of p-Smad1/5, total Smad1/5, p-Smad2/3, and total Smad2/3. B and C: bar graphs showing the changes in protein levels of p-Smad1/5 and p-Smad2/3. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Incubation, Western Blot, Control

    BMP4 inhibits PDGF-induced calpain activation that initiates the intracrine TGF-β1 signaling pathway in normal PASMCs from conduit pulmonary arteries. A: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5–24 h after which calpain activity was determined as described in materials and methods. B and C: PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h after which intracellular active TGF-β1 was measured by nondenaturing electrophoresis and Western blot analysis. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 inhibits PDGF-induced calpain activation that initiates the intracrine TGF-β1 signaling pathway in normal PASMCs from conduit pulmonary arteries. A: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5–24 h after which calpain activity was determined as described in materials and methods. B and C: PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h after which intracellular active TGF-β1 was measured by nondenaturing electrophoresis and Western blot analysis. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activation Assay, Incubation, Activity Assay, Electrophoresis, Western Blot, Control

    The inhibitory effect of BMP4 on PDGF signaling pathway is not through Smad1/5 in normal PASMCs from conduit pulmonary arteries. A–D: PASMCs were transfected with siRNAs against Smad1/5 and control siRNA. After 72 h, the cells were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h. Then calpain activity was measured by using kinetic method, and p-Smad1/5, total Smad1/5, p-Smad2/3, total Smad2/3, and intracellular active TGF-β1 were measured by Western blot. E and F: after transfection with siRNAs against Smad1/5 and control siRNA, PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which collagen-I protein was measured by Western blot analysis. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. PDGF within control siRNA group; #P < 0.05 vs. PDGF within Smad1/5 siRNA group.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: The inhibitory effect of BMP4 on PDGF signaling pathway is not through Smad1/5 in normal PASMCs from conduit pulmonary arteries. A–D: PASMCs were transfected with siRNAs against Smad1/5 and control siRNA. After 72 h, the cells were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h. Then calpain activity was measured by using kinetic method, and p-Smad1/5, total Smad1/5, p-Smad2/3, total Smad2/3, and intracellular active TGF-β1 were measured by Western blot. E and F: after transfection with siRNAs against Smad1/5 and control siRNA, PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which collagen-I protein was measured by Western blot analysis. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. PDGF within control siRNA group; #P < 0.05 vs. PDGF within Smad1/5 siRNA group.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Transfection, Control, Incubation, Activity Assay, Western Blot

    The inhibitory effect of BMP4 is not due to inhibiting PDGF-induced phosphorylation of Src or ERK in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which p-Src, total Src, p-ERK, and total ERK were measured by Western blot analysis. A and C: representative immunoblots of p-Src, total Src, p-ERK, and total ERK. B and D: bar graph depicting the changes in p-Src and p-ERK. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control (without PDGF and BMP4); #P < 0.05 vs. BMP4.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: The inhibitory effect of BMP4 is not due to inhibiting PDGF-induced phosphorylation of Src or ERK in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which p-Src, total Src, p-ERK, and total ERK were measured by Western blot analysis. A and C: representative immunoblots of p-Src, total Src, p-ERK, and total ERK. B and D: bar graph depicting the changes in p-Src and p-ERK. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control (without PDGF and BMP4); #P < 0.05 vs. BMP4.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Phospho-proteomics, Incubation, Western Blot, Control

    BMP4 increases PKA activity, and forskolin recapitulates and myristoylated protein kinase inhibitor (mPKI) prevents the inhibitory effects of BMP4 in normal PASMCs from conduit pulmonary arteries. A: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which PKA activity was measured as described in materials and methods. B: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of forsklin (10 μM) for 0.5 h after which calpain activity was measured as described in materials and methods. C: PASMCs treated with vehicle or PKI were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which calpain activity was measured as described in materials and methods. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control (without PDGF, BMP4 or forskolin); #P < 0.05 vs. PDGF; **P < 0.05 vs. PDGF in vehicle.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 increases PKA activity, and forskolin recapitulates and myristoylated protein kinase inhibitor (mPKI) prevents the inhibitory effects of BMP4 in normal PASMCs from conduit pulmonary arteries. A: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which PKA activity was measured as described in materials and methods. B: PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of forsklin (10 μM) for 0.5 h after which calpain activity was measured as described in materials and methods. C: PASMCs treated with vehicle or PKI were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which calpain activity was measured as described in materials and methods. Results are expressed as means ± SE; n = 5. *P < 0.05 vs. control (without PDGF, BMP4 or forskolin); #P < 0.05 vs. PDGF; **P < 0.05 vs. PDGF in vehicle.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activity Assay, Incubation, Control

    The inhibitory effect of BMP4 on PDGF-induced calpain-2 activation, cell proliferation, and collagen synthesis is abolished by knocking-down PKA in normal PASMCs from conduit pulmonary arteries. A–D: PASMCs were transfected with siRNAs against PKA and control siRNA. After 72 h, the cells were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h. Then, calpain activity was measured by using kinetic method (A and B). Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2 (C and D). A, E, and F: after transfection with siRNAs against PKA and control siRNA, PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which collagen-I protein (A and E) were measured by Western blot and cell proliferation (F) was measured by detecting BrdU incorporation. A and C: representative immunoblots of PKA, collagen-I, and p-Ser369-calpain-2. B, D, E, and F: bar graph depicting the changes in calpain activity, p-Ser369-calpain-2, collagen-I protein level, and cell proliferation. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. PDGF within control siRNA group.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: The inhibitory effect of BMP4 on PDGF-induced calpain-2 activation, cell proliferation, and collagen synthesis is abolished by knocking-down PKA in normal PASMCs from conduit pulmonary arteries. A–D: PASMCs were transfected with siRNAs against PKA and control siRNA. After 72 h, the cells were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 2 h. Then, calpain activity was measured by using kinetic method (A and B). Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2 (C and D). A, E, and F: after transfection with siRNAs against PKA and control siRNA, PASMCs were incubated with PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which collagen-I protein (A and E) were measured by Western blot and cell proliferation (F) was measured by detecting BrdU incorporation. A and C: representative immunoblots of PKA, collagen-I, and p-Ser369-calpain-2. B, D, E, and F: bar graph depicting the changes in calpain activity, p-Ser369-calpain-2, collagen-I protein level, and cell proliferation. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. PDGF within control siRNA group.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activation Assay, Transfection, Control, Incubation, Activity Assay, Immunoprecipitation, Western Blot, BrdU Incorporation Assay

    BMP4 attenuates the dephosphorylation of calpain-2 at serine-369 (p-Ser369) in PDGF-treated PASMCs in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which cells were lysed and calpain-2 proteins in cell lysates were measured by Western blot analysis. Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser50-calpain-2 or p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2. A: representative immunoblots of calpain-2 protein. B: representative immunoblots of the immunoprecipitates for p-Ser50-calpain-2 or p-Ser369-calpain-2. C: bar graph showing the changes in the levels of p-Ser50-calpain-2 or p-Ser369-calpain-2. Results are expressed as means ± SE; n = 3. *P < 0.01 vs. control for p-Ser50-calpain-2; **P < 0.05 vs. control for p-Ser369-calpain-2.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 attenuates the dephosphorylation of calpain-2 at serine-369 (p-Ser369) in PDGF-treated PASMCs in normal PASMCs from conduit pulmonary arteries. PASMCs were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which cells were lysed and calpain-2 proteins in cell lysates were measured by Western blot analysis. Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser50-calpain-2 or p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2. A: representative immunoblots of calpain-2 protein. B: representative immunoblots of the immunoprecipitates for p-Ser50-calpain-2 or p-Ser369-calpain-2. C: bar graph showing the changes in the levels of p-Ser50-calpain-2 or p-Ser369-calpain-2. Results are expressed as means ± SE; n = 3. *P < 0.01 vs. control for p-Ser50-calpain-2; **P < 0.05 vs. control for p-Ser369-calpain-2.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: De-Phosphorylation Assay, Incubation, Western Blot, Immunoprecipitation, Control

    BMP4 inhibits PDGF-stimulated cell proliferation and collagen synthesis in normal PASMCs from peripheral type-III pulmonary arteries. Normal PASMCs from peripheral type-III pulmonary arteries were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting BrdU incorporation and intracellular collagen-I protein level (B and C) were measured by Western blot. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 inhibits PDGF-stimulated cell proliferation and collagen synthesis in normal PASMCs from peripheral type-III pulmonary arteries. Normal PASMCs from peripheral type-III pulmonary arteries were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting BrdU incorporation and intracellular collagen-I protein level (B and C) were measured by Western blot. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control; #P < 0.05 vs. PDGF.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Incubation, BrdU Incorporation Assay, Western Blot, Control

    BMP4 does not attenuate PDGF-induced increases in cell proliferation, collagen-I protein levels, and calpain activation in PASMCs from peripheral type-III pulmonary arteries of idiopathic pulmonary arterial hypertension (PAH) patients. PASMCs from peripheral type-III pulmonary arteries of PAH patients were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting BrdU incorporation and intracellular collagen-I protein levels (B and C) and calpain activity (D; 30-min incubation) were measured. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control; **P < 0.05 vs. BMP4.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 does not attenuate PDGF-induced increases in cell proliferation, collagen-I protein levels, and calpain activation in PASMCs from peripheral type-III pulmonary arteries of idiopathic pulmonary arterial hypertension (PAH) patients. PASMCs from peripheral type-III pulmonary arteries of PAH patients were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 24 h after which cell proliferation (A) was measured by detecting BrdU incorporation and intracellular collagen-I protein levels (B and C) and calpain activity (D; 30-min incubation) were measured. B: representative immunoblots of collagen-I. C: bar graph showing the changes in protein levels of collagen-I. Results are expressed as means ± SE; n = 4. *P < 0.05 vs. control; **P < 0.05 vs. BMP4.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activation Assay, Incubation, BrdU Incorporation Assay, Activity Assay, Western Blot, Control

    BMP4 does not induce PKA activation and does not prevent PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in PASMCs from peripheral type-III pulmonary arteries of IPAH patients. PASMCs from peripheral type-III pulmonary arteries of IPAH patients were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which after which PKA activity was measured as described in materials and methods (A). Some cells were lysed and calpain-2 proteins in cell lysates were measured by Western blot analysis (B). Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser50-calpain-2 or p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2 (C and D). B: representative immunoblots of calpain-2 protein. C: representative immunoblots of the immunoprecipitates for p-Ser50-calpain-2 or p-Ser369-calpain-2. D: bar graph showing the changes in the levels of p-Ser50-calpain-2 or p-Ser369-calpain-2. Results are expressed as means ± SE; n = 4. *P < 0.01 vs. control; **P < 0.01 vs. BMP4.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: BMP4 does not induce PKA activation and does not prevent PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in PASMCs from peripheral type-III pulmonary arteries of IPAH patients. PASMCs from peripheral type-III pulmonary arteries of IPAH patients were incubated with and without PDGF-BB (10 ng/ml) in the presence and absence of BMP4 (30 ng/ml) for 0.5 h after which after which PKA activity was measured as described in materials and methods (A). Some cells were lysed and calpain-2 proteins in cell lysates were measured by Western blot analysis (B). Some cell lysates were subjected to immunoprecipitation using specific antibodies against p-Ser50-calpain-2 or p-Ser369-calpain-2. The immunoprecipitates were subjected to immunoblots against calpain-2 (C and D). B: representative immunoblots of calpain-2 protein. C: representative immunoblots of the immunoprecipitates for p-Ser50-calpain-2 or p-Ser369-calpain-2. D: bar graph showing the changes in the levels of p-Ser50-calpain-2 or p-Ser369-calpain-2. Results are expressed as means ± SE; n = 4. *P < 0.01 vs. control; **P < 0.01 vs. BMP4.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activation Assay, Phospho-proteomics, Incubation, Activity Assay, Western Blot, Immunoprecipitation, Control

    A schematic pathway illustrating the inhibitory effects of BMP4 on PDGF-induced calpain-2 activation, cell proliferation, and collagen synthesis in normal and PAH PASMCs.

    Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

    Article Title: BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

    doi: 10.1152/ajplung.00260.2016

    Figure Lengend Snippet: A schematic pathway illustrating the inhibitory effects of BMP4 on PDGF-induced calpain-2 activation, cell proliferation, and collagen synthesis in normal and PAH PASMCs.

    Article Snippet: To determine the effect of BMP4 on PDGF signaling pathway, normal human PASMCs from conduit pulmonary arteries (Lonza) were incubated with PDGF-BB (10 ng/ml) in the absence and presence of BMP4 (30 ng/ml) for 24 h, and cell proliferation and intracellular collagen were then determined.

    Techniques: Activation Assay